⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
Latest News
ESMO 2026 Presentations Deepen the Evidence Base for Natera’s Oncology Portfolio and Leadership in Ultrasensitive MRD Technology
businesswire.com
NTRA
Eikon Therapeutics Announces Availability of Seven Abstracts for Presentation at the European Society for Medical Oncology Congress
globenewswire.com
EIKN
Zentalis Pharmaceuticals Announces First Overall Survival Data for Azenosertib from DENALI Part 1b Published in ESMO Congress 2026 Abstract
globenewswire.com
ZNTL
Incyte to Highlight Key Oncology Data Presentations at the European Society for Medical Oncology (ESMO) Congress 2026
businesswire.com
INCY
Lilly to showcase advances across its oncology pipeline at the 2026 European Society for Medical Oncology (ESMO) Congress
prnewswire.com
LLY
Veradermics to Hold Conference Call to Discuss Topline Results from Phase 3 ‘304’ Clinical Trial of VDPHL01 in Males with Mild-to-Moderate Pattern Hair Loss
businesswire.com
MANE
Lost Money on Doximity, Inc. (DOCS)? Contact Levi & Korsinsky Before November 16, 2026 to Join Class Action
accessnewswire.com
DOCS
BMBL Stock Alert: Halper Sadeh LLC is Investigating Whether Bumble Inc. is Obtaining a Fair Price for its Shareholders
businesswire.com
BMBL
Class Action Filed Against Webull Corporation (BULL) Over Securities Violations – Contact Levi & Korsinsky Today
accessnewswire.com
BULL
Disc Medicine to Host Corporate Webcast to Discuss Topline Results from the APOLLO Phase 3 Trial of Bitopertin in Erythropoietic Protoporphyria (EPP)
globenewswire.com
IRON